
P1.03-054 A Phase II Randomized Trial of Gefitinib Alone vs Olaparib Plus Gegitinib in Advanced NSCLC EGFRmut + Goal Trial Spanish Lung Cancer Group
Massuti, B., Campelo, R. García, Arrieta, O., Rodríguez-Abreu, D., Granados, A.L. Ortega, Majem, M., Baz, D. Vicente, Lianes, P., Barrera, J. Bosch, Insa, A., Domine, M., Reguart, N., Guirado, M., SalVolume:
12
Langue:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.09.859
Date:
November, 2017
Fichier:
PDF, 460 KB
english, 2017